cancer of the cervix cervical cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients should be at least 18 years of age; - Patients should be able and willing to provide informed consent; - Patients should have the clinical diagnosis of cervical cancer; - Patients are scheduled for: 1. Primary external beam radiotherapy (EBRT) with intra-uterine brachytherapy (BT); 2. Primary EBRT with intra-uterine brachytherapy (BT) and concurrent chemotherapy (Cisplatin); 3. Primary EBRT with intra-uterine brachytherapy (BT) and combined with hyperthermia; 4. Adjuvant, post-operative external beam radiotherapy (EBRT); 5. Adjuvant, post-operative EBRT with concurrent chemotherapy (Cisplatin).
Exclusion criteria
Exclusion criteria: - Any medical condition that may interfere with the study objectives; - Positive test result for HIV or Hepatitis B; - Any other active malignancy than cervical cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time-related immuneresponse during and after treatment with radiotherapy in cervical cancer patients. T cell phenotypic changes and T cell-related immune cell functional changes will be investigated. | — |
Countries
Netherlands